Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Cirrhosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Cirrhosis
    Liver Transplant Outcomes Similar for Patients With Nonalcoholic vs Alcoholic Cirrhosis - (DGNews)
    TopAbstracts in Cirrhosis 11/17/2009 - (DGNews)
    Satavaptan Shows Poor Survival, Despite Modest Effectiveness in the Management of Recurrent Ascites: Presented at AASLD - (DGDispatch)
    Viral Load Predicts Outcome of Liver Transplant Recipients With Hepatitis C: Presented at AASLD - (DGDispatch)
    Rifaximin Protects Patients With Cirrhosis From Breakthrough Hepatic Encephalopathy Over Long Term: Presented at AASLD - (DGDispatch)

    News archive

     Recent webcasts/CME - Cirrhosis

    Webcasts/CME archive

     Recent cases - Cirrhosis
      Incisional Hernia as an Unusual Cause of Hepatic Encephalopathy in a 62-Year-Old Man with Cirrhosis: A Case Report
      Gefitinib for Non-Small Cell Lung Cancer Patients with Liver Cirrhosis
      Intra-Hepatic Splenosis as an Unexpected Cause of a Focal Liver Lesion in a Patient with Hepatitis C and Liver Cirrhosis: A Case Report
      Black Esophagus
      A Case of Non-O1 and Non-O139 Vibrio cholerae Septicemia with Endophthalmitis in a Cirrhotic Patient

      Cases archive
        




      my personal edition > cirrhosis > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Misoprostol Produces Consistent Nitrogen Sparing In Cirrhosis Patients

      A DGReview of :"Effects of long-term oral misoprostol administration on hepatic amino acid-nitrogen metabolism in patients with cirrhosis"
      Journal of Hepatology

      07/24/2002
      By Harvey McConnell


      A consistent nitrogen sparing mechanism has been found to be produced by misoprostol in patients with cirrhosis, and the effects are not mediated by hormone levels.

      The effects found in the study of long-term oral misoprostol administration on hepatic amino acid-nitrogen metabolism in patients with cirrhosis may prove to be beneficial in clinical hepatology, declares Dr. Giampaolo Bianchi and colleagues at the University of Bologna, Bologna, Italy. They say controlled trials are now needed to assess the effects found in their study.

      The clinicians point out that the acute infusion of a prostaglandin of E series 1 (PGE1) analogue produces nitrogen sparing among patients with cirrhosis. In order to test the effects of long-term oral PGE1 on hepatic and whole-body nitrogen metabolism, they enrolled 10 patients with advanced cirrhosis.

      The patients were studied in paired experiments before and 30-50 days after they had received oral misoprostol therapy.

      Alpha-amino-nitrogen levels and urea-nitrogen synthesis rate were measured in the post-absorption state, and in response to continuous alanine infusion at 2 mmol/kg per hour for 4.5 hours. The data obtained were used to compute the functional hepatic nitrogen clearance.

      Dr. Bianchi and colleagues found that misoprostol reduced urea-nitrogen synthesis rate, both during fasting and in response to alanine, and this resulted in a positive nitrogen exchange. There was a slight increase in functional hepatic nitrogen clearance, with the indication of a reduced urea synthesis rate at any alpha-amino-N concentration.

      There was no accumulation in plasma of either amino acid- and ammonia-N. In addition, the clinicians did not observe any systematic effects on insulin and glucagon.
      Journal of Hepatology, Vol. 37 (1) (2002) pp. 15-21. "Effects of long-term oral misoprostol administration on hepatic amino acid-nitrogen metabolism in patients with cirrhosis"

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send